X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs PFIZER - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA PFIZER FULFORD INDIA/
PFIZER
 
P/E (TTM) x 398.8 24.3 1,639.8% View Chart
P/BV x 6.2 3.9 160.7% View Chart
Dividend Yield % 0.1 0.8 10.1%  

Financials

 FULFORD INDIA   PFIZER
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
PFIZER
Mar-16
FULFORD INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs9422,724 34.6%   
Low Rs4501,611 27.9%   
Sales per share (Unadj.) Rs691.4440.9 156.8%  
Earnings per share (Unadj.) Rs11.548.7 23.5%  
Cash flow per share (Unadj.) Rs15.475.8 20.3%  
Dividends per share (Unadj.) Rs2.0015.00 13.3%  
Dividend yield (eoy) %0.30.7 41.5%  
Book value per share (Unadj.) Rs380.0462.9 82.1%  
Shares outstanding (eoy) m3.9045.75 8.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.9 20.5%   
Avg P/E ratio x60.744.5 136.4%  
P/CF ratio (eoy) x45.328.6 158.4%  
Price / Book Value ratio x1.84.7 39.1%  
Dividend payout %17.430.8 56.6%   
Avg Mkt Cap Rs m2,71499,163 2.7%   
No. of employees `0000.42.9 15.4%   
Total wages/salary Rs m5052,758 18.3%   
Avg. sales/employee Rs Th6,073.06,981.7 87.0%   
Avg. wages/employee Rs Th1,137.4954.5 119.2%   
Avg. net profit/employee Rs Th100.7771.1 13.1%   
INCOME DATA
Net Sales Rs m2,69620,170 13.4%  
Other income Rs m125857 14.6%   
Total revenues Rs m2,82221,028 13.4%   
Gross profit Rs m-464,310 -1.1%  
Depreciation Rs m151,239 1.2%   
Interest Rs m105 182.7%   
Profit before tax Rs m543,923 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m101,794 0.5%   
Profit after tax Rs m452,228 2.0%  
Gross profit margin %-1.721.4 -8.1%  
Effective tax rate %17.745.7 38.7%   
Net profit margin %1.711.0 15.0%  
BALANCE SHEET DATA
Current assets Rs m1,73816,299 10.7%   
Current liabilities Rs m5457,594 7.2%   
Net working cap to sales %44.343.2 102.6%  
Current ratio x3.22.1 148.7%  
Inventory Days Days4865 74.2%  
Debtors Days Days426 16.7%  
Net fixed assets Rs m128,622 0.1%   
Share capital Rs m39458 8.5%   
"Free" reserves Rs m1,44320,722 7.0%   
Net worth Rs m1,48221,180 7.0%   
Long term debt Rs m025 0.0%   
Total assets Rs m2,07729,137 7.1%  
Interest coverage x6.7755.5 0.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.7 187.6%   
Return on assets %2.67.7 34.1%  
Return on equity %3.010.5 28.7%  
Return on capital %4.319.0 22.7%  
Exports to sales %00.1 0.0%   
Imports to sales %24.517.5 139.9%   
Exports (fob) Rs mNA12 0.0%   
Imports (cif) Rs m6593,526 18.7%   
Fx inflow Rs m1752 33.3%   
Fx outflow Rs m673140 480.9%   
Net fx Rs m-656-88 742.6%   
CASH FLOW
From Operations Rs m903,436 2.6%  
From Investments Rs m105-6,991 -1.5%  
From Financial Activity Rs m-14-619 2.3%  
Net Cashflow Rs m181-4,174 -4.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 3.8 7.5 50.7%  
FIIs % 0.1 4.9 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 23.7 89.5%  
Shareholders   4,783 85,207 5.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   PANACEA BIOTECH  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  DIVIS LABORATORIES  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS